PT Phapros TbkISX:PEHA -0.86%73 Interest Coverage is 0.93 as of Mar. 2026, which is 49% below its 10-year median of 1.81. GuruFocus rates ISX:PEHA with a GF Score™ of 73/100 and a GF Value™ of Rp385.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 686 Drug Manufacturers companies, PT Phapros Tbk ranks worse than 85.86% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. PT Phapros Tbk's
Operating Income
for the
three
months ended in Mar. 2026 was Rp10,002 Mil. PT Phapros Tbk's Interest Expense for the
three
months ended in Mar. 2026 was Rp-10,764 Mil.
PT Phapros Tbk's interest coverage for the quarter that ended in Mar. 2026 was 0.93.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for PT Phapros Tbk's Interest Coverage or its related term are showing as below:
ISX:PEHA'
s Interest Coverage Range Over the Past 10 Years
Min: 0.67 Med: 1.81 Max: 11.04
Current: 2
ISX:PEHA's Interest Coverage is ranked worse than 85.86% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.725
vs ISX:PEHA: 2.00
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
PT Phapros Tbk Interest Coverage Related Terms
PT Phapros Tbk Interest Coverage Historical Data
* Premium members only.
The historical data trend for PT Phapros Tbk's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ISX:PEHA vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Phapros Tbk's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Phapros Tbk Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Phapros Tbk's Interest Coverage distribution charts can be found below:
* The bar in red indicates where PT Phapros Tbk's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Phapros Tbk (ISX:PEHA) has a Interest Coverage of 0.93 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on PT Phapros Tbk and its competitors. This is 49% below median its historical median of 1.81. Over the past decade, PT Phapros Tbk's Interest Coverage has ranged from 0.67 to 11.04. According to the industry distribution chart, PT Phapros Tbk ranks #589 out of 686 companies in the Drug Manufacturers industry, placing it in the top 85.9%.
Is PT Phapros Tbk's Interest Coverage too high?
PT Phapros Tbk's current Interest Coverage of 0.93 is 49% below median its 10-year median of 1.81. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 11.04. The Drug Manufacturers industry median Interest Coverage is 12.73. PT Phapros Tbk's value of 0.93 is 92.7% below this industry median. Based on the distribution chart, PT Phapros Tbk ranks #589 out of 686 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PT Phapros Tbk has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Phapros Tbk ranks #589 out of 686 companies for Interest Coverage. This places PT Phapros Tbk in the lower half of its industry. The industry median Interest Coverage is 12.73. PT Phapros Tbk's value of 0.93 is 92.7% below this benchmark. Historically, PT Phapros Tbk's own Interest Coverage has ranged from 0.67 to 11.04 over the past decade. While the company's 10-year median is 1.81 vs. the industry median of 12.73, PT Phapros Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.73, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Phapros Tbk's current Interest Coverage of 0.93 is 92.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on PT Phapros Tbk and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Phapros Tbk's current Interest Coverage is 0.93, which is 49% below median its own 10-year median of 1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp385.32, compared to a current price of Rp230.00 — trading 40.3% below its estimated fair value. The current Interest Coverage is 0.93, which is 49% below median its 10-year median of 1.81 and 92.7% below the Drug Manufacturers industry median of 12.73. PT Phapros Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current Interest Coverage is 0.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued.
The current stock price of Rp230.00 is trading 40.3% below its estimated GF Value™ of Rp385.32.
GuruFocus considers PT Phapros Tbk to be Possible Value Trap.
Key valuation signals for ISX:PEHA:
Interest Coverage: 0.93 (49% below median its 10-year median of 1.81)
GF Value™: Rp385.32 vs. price of Rp230.00 (40.3% below fair value)
Industry Position: 92.7% below the Drug Manufacturers median (#589 of 686)
No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
73GF Score
Get the complete analysis for ISX:PEHA
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PEHA has been successfully added to your 
